Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1998-06-19
2000-08-08
Weber, Jon P.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
435195, 435196, 435197, A61K 3846, C12N 918, C12N 916, C12N 914
Patent
active
060998369
ABSTRACT:
The present invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Also provided are materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products which are expected to be useful in regulating pathological inflammatory events. Specifically disclosed are methods for the treatment of reperfusion injury using platelet-activating factor acetylhydrolase products.
REFERENCES:
patent: 5019508 (1991-05-01), Johnson et al.
patent: 5279957 (1994-01-01), Gross
patent: 5532152 (1996-07-01), Cousens et al.
patent: 5641669 (1997-06-01), Cousens et al.
patent: 5981252 (1999-11-01), MacPhee et al.
Ambrosio et al., "Superoxide Radicals Irreversibly Inactivate Plasma Acetylhydrolase, the Enzyme that Catabolizes Platelet-Activating Factor", Circulation, vol. 88, No. 4, Part 2, p. I-444, Abstract # 2389, Oct. 1993.
Turk et al., "Quantification of Distinct Molecular Species of the 2-Lyso Metabolite of Platelet-Activating Factor by Gas Chromatography-Negative-Ion Chemical Ionization Mass Spectrometry", J. Chromatog., vol. 575, No. 2, pp. 183-196, Feb. 1992.
Adjei and Garren, "Pulmonary Delivery of Peptide Drugs: Effect of Particle Size on Bioavailability of Leuprolide Acetate in Healthy Male Volunteers," Pharm. Res., 7(6):565-569 (1990).
Basran, G.S., "Properties of Platelet Activating Factor (PAF-Acether) Which Suggest Involvement in Chronic Inflammation and Persistent Asthma," Br. J. Pharmacol., 77:437 (1982).
Braquet et al., "Effect of Endothelin-1 on Blood Pressure and Bronchopulmonary System of the Guinea Pig," J. Cardio. Pharm., 13(Supp. 5):S143-S146 (1989).
Brenner, "The Molecular Evolution of Genes and Proteins: A Tale of Two Serines," Nature, 334:528-530 (Aug. 11, 1988).
Capecchi, "Altering the Genome by Homologous Recombination," Science, 224:1288-1292 (Jun. 16, 1989).
Caplan et al., "Role of Platelet Activating Factor and Tumor Necrosis Factor-alpha in Neonatal Necrotizing Enterocolitis," J. Pediatr., 116(6):960-964 (Jun. 1990).
Chapus et al., "Minireview on Pancratic Lipase and Colipase," Biochimie, 70:1223-1234 (1988).
De Boer et al., "the tac Promoter: A Functional Hybrid Derived from the trp and lac promoters," Proc. Natl. Acad. Sci. USA, 80:21-25 (Jan. 1983).
Debs et al., "Lung-Specific Delivery of Cytokines Induces Sustained Pulmonary and Systemic Immunomodulation in Rats," J. Immunol., 1409(10):3482-3488 (May 15, 1988).
Denizot et al., "PAF-Acether and Acetylhydrolase in Stool of Patients with Crohn's Disease," Digestive Diseases and Sciences, 37(3):432-437 (Mar. 1992).
Furukawa et al., "Platelet-Activating Factor-Induced Ischemic Bowel Necrosis: The Effect of Platelet-Activating Factor Acetylhydrolase," Ped. Res., 34(2):237-241 (1993).
Grino et al., "BN 52021: A Platelet Activating Factor Antagonist for Preventing Post-Transplant Renal Failure," Anna. Int. Med., 121(5):345-347 (Sep. 1, 1994).
Hahn et al., "The Complete Sequences of Plasmids pFNeo and pMH-Neo: Convenient Expression Vectors for High-level Expression of Eukaryotic Genes in Hematopoietic Cell Lines," Gene, 127:267-268 (1993).
Handley and Saunders, "Platelet Activating Factor and Inflammation in Atherogenesis: Targets for Drug Development," Drug. Dev. Res., 7:361-375 (1986).
Hattori et al., "Purification and Characterization of Bovine Brain Platelet-activating Factor Acetylhydrolase," J. Biol. Chem., 268(25):18748-18753 (Sep. 5, 1993).
Hattori et al., "The Catalytic Subunit of Bovine Brain Platelet-activating Factor Acetylhydrolase Is a Novel Type of Serine Esterase," J. Biol. Chem., 269(37):23150-23155 (Sep. 16, 1994).
Henriques et al., "Endothelin-1 Inhibits PAF-induced Paw Oedema and Pleurisy in the Mouse," Br. J. Pharmacol., 106:579-582 (1992).
Heuer, H.O., "Current Status of PAF Antagonists," Clin. Ep. Allergy, 22:980-983 (1992).
Hoffman et al., "Detection of Platelet-activating Factor in Amniotic Fluid of Complicated Pregnancies," Am. J. Obstet. Gynecol., 162(2):525-528 (1990).
Horwitz et al., "DNA Sequences of the araBAD-araC Controlling Region in Salmonella typhimurium LT2," Gene, 14:309-319 (1981).
Hsieh and Ng, "Increased Plasma Platelet-activating Factor in Children with Acute Asthmatic Attacks and Decreased in vivo and in vitro Production of Platelet-activating Factor after Immunotherapy," J. Allergy Clin. Immunol., 91:650-657 (Feb. 1993).
Hsueh et al., "Platelet-activating Factor, Tumor Necrosis Factor, Hypoxia and Necrotizing Enterocolitis," Acta P.oe butted.diatr., Suppl. 396:11-17 (1994).
Hubbard et al., "Anti-Neutrophil-Elastase Defenses of the Lower Respiratory Tract in .alpha.1-Antitrypsin Deficiency Directly Augmented with an Aerosol of .alpha.1-Antitrypsin," Annals of Internal Medicine, III(3):206-212 (Aug. 1, 1989).
Kald et al., "Release of Platelet-Activating Factor in Acute Experimental Pancreatitis," Pancreas, 8(4):440-442 (1993).
Kirsch et al., "Mechanism of Platelet Activating Factor-Induced Vascular Leakage in the Rat Trachea," Expl. Lung Res., 18:447-459 (1992).
Kurosawa et al., "Increased Levels of Blood Platelet-Activating Factor in Bronchial Asthmatic Patients with Active Symptoms," Allergy, 49:60-63 (1994).
LaVallie et al., "A Thiroedoxin Fusion Expression System That Circumvents Inclusion Body Formation in the E. coli Cytoplasm," Bio/Technology, 11:187-193 (Feb. 11, 1993).
Lellouch-Tubiana et al., "Eosinophil Recruitment into Guinea Pig Lungs after PAF-acether and Allergen Administration," Am. Rev. Respit. Dis., 137;948-954 (1988).
Lellouch-Tubiana et al., "Ultrastructural Evidence for Extravascular Platelet Recruitment in the Lung Upon Intravenous Injection of Platelet-activating Factor (PAF-acether) to Guinea-pigs," Br. J. exp. Path., 66:345-355 (1985).
Lewin, pp. 136-141 in Genes V, Oxford University Press, New York, New York (1994).
Lindsberg et al., "Evidence for Platelet-Activating Factor as a Novel Mediator in Experimental Stroke in Rabbits," Stroke, 21(10):1452-1457 (Oct. 1990).
Lindsberg et al., "Platelet-activating Factor in Stroke and Brain Injury," Ann. Neurol., 30(2):117-129 (Aug. 1991).
Maki et al., "Platelet-activating Factor Acetylhydrolase Activity in Maternal, Fetal, and Newborn Rabbit Plasma During Pregnancy and Lactation," Proc. Natl. Acad. Sci. USA, 85:728-732 (Feb. 1988).
Matsumoto et al., "Platelet-Activating Factor in Bronchoalveolar Lavage Fluid of Patients with Adult Respiratory Distress Syndrome," Clin. Exp. Pharmacol. Physiol., 19:509-515 (1992).
Matsuzaki et al., "PAF Acetylhydrolase Activities in Human Systemic Lupus Erythematosus and Lupus-prone Mice," Clinica Chimica Acta, 210:139-144 (1992).
Mezzano et al., "Detection of Platelet-Activating Factor in Plasma of Patients with Steptococcal Nephritis," J. Am. Soc. Nephrol., 4:235-242 (1993).
Miwa et al., "Characterization of Serum Platelet-activating Factor (PAF) Acetylhydrolase," J. Clin. Invest., 82:1983-1991 (Dec. 1988).
Rabinovici et al., "ARDS-like Lung Injury Produced by Endotoxin in Platelet-Activating Factor-primed Rats," J. Appl. Physiol., 74(4):1791-1802 (1993).
Rabinovici et al., "Platelet Activating Factor Mediates Interleukin-2-induced Lung Injury in the Rat," J. Clin. Invest., 89:1669-1673 (May 1992).
Rodriguez-Roisin et al., "Platelet-activating Factor Causes Ventilation-Perfusion Mismatch in Humans," J. Clin. Invest., 93:188-194 (Jan. 1994).
Sandhu et al., "Amplification of Reproducible Allele Markers for Amplified Fragment Length Polymorphism Analysis," Biotechniques, 12(1):14-16 (1992).
Satoh et al., "Platelet-activating Factor (PAF) Stimulates the Production of PAF Acetylhydrolase by the Human Hepatoma Cell Line, HepG2," J. Clin. Invest., 87:476-481 (Feb. 1991).
Satoh et al., "Platelet-Activating Factor Acetylhydrolase in Plasma Lipoproteins from Patients with Ischemic Stroke," Stroke, 23:1090-1092 (1992).
Smith et al., "Pulmonary Deposition and Clearance of Aerosolized Alpha-1-Proteinase Inhibitor Administered to Dogs and to Sheep," J. Clin. Invest., 84:1145-1154 (Oct. 1989).
Stafforini et al., "Human Macrophages Secrete Platelet-activating Factor Acetylhydrolase,"
Cousens Lawrence S.
Eberhardt Christine D.
Gray Patrick
Tjoelker Larry W.
Trong Hai Le
ICOS Corporation
Weber Jon P.
LandOfFree
Platelet-activating factor acetylhydrolase (PAF-AH) therapeutic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platelet-activating factor acetylhydrolase (PAF-AH) therapeutic , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platelet-activating factor acetylhydrolase (PAF-AH) therapeutic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1147679